代谢与心血管疾病论坛-1
Metabolism and Cardiovascular Disease Forum-1
Metabolism and Cardiovascular Disease Forum-1
2024年11月22日 星期五
|
10:30-12:30 404 |
|---|
| 主持 Moderators | 徐亚伟 Yawei XU, 蒋峻 Jun JIANG | ||
| 讨论嘉宾 Discussants | 潘小宏 Xiaohong PAN, 许东航 Donghang XU, 马丽珍 Lizhen MA | ||
|
10:30-10:35 |
开场致辞 Opening Remarks |
徐亚伟Yawei XU 蒋峻Jun JIANG |
|
|
10:35-10:55 |
中国心力衰竭诊断和治疗指南2024更新 Updates:2024 China Guidelines for the Diagnosis and Treatment of Heart Failure |
袁红 Hong YUAN | |
|
10:55-11:15 |
SGLT2i心血管获益潜在机制的证据和启示 Evidence and Implications for the Underlying Mechanism of SGLT2i Cardiovascular Benefit |
苏蓝 Lan SU | |
|
11:15-11:35 |
跨界糖心肾-SGLT-2i CRM探索之旅 Cross T2D/HF/CKD- SGLT-2i CRM Exploration Tour |
谷卫 wei GU | |
|
11:35-11:55 |
不忘初心，砥砺前行:从CVOT看SGLT-2i 治疗T2DM的革新之路 The Innovation of SGLT-2i in the Treatment of T2DM From the Perspective of CVOT |
董凤芹 Fengqin DONG | |
|
11:55-12:25 |
讨论：1.从您的角度，如何优化心衰GDMT的强化应用？2.从您的学科出发，应如何做好心衰的预防和早期干预及综合管理措施？ Discussion: 1: From Your Perspective, How can you Optimize the Intensive Application of GDMT for Heart Failure? 2: From the Perspective of Your Discipline, How Should us do a Good Job in the Prevention, Early Intervention and Comprehensive Management of Heart Failure? |
||
|
12:25-12:30 |
总结 Summary |
徐亚伟Yawei XU |
|